These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7528711)

  • 1. Plasma levels of substance P in liver cirrhosis: relationship to the activation of vasopressor systems and urinary sodium excretion.
    Fernández-Rodriguez CM; Prieto J; Quiroga J; Zozoya JM; Andrade A; Núñez M; Sangro B; Penas J
    Hepatology; 1995 Jan; 21(1):35-40. PubMed ID: 7528711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma substance P levels in patients with liver cirrhosis: relationship to systemic and portal hemodynamics.
    Lee FY; Lin HC; Tsai YT; Chang FY; Lu RH; Hou MC; Li CP; Chu CJ; Wang SS; Lee SD
    Am J Gastroenterol; 1997 Nov; 92(11):2080-4. PubMed ID: 9362197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of increased plasma adrenomedullin concentration in patients with cirrhosis.
    Kojima H; Tsujimoto T; Uemura M; Takaya A; Okamoto S; Ueda S; Nishio K; Miyamoto S; Kubo A; Minamino N; Kangawa K; Matsuo H; Fukui H
    J Hepatol; 1998 May; 28(5):840-6. PubMed ID: 9625320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arteriovenous shunting, hemodynamic changes, and renal sodium retention in liver cirrhosis.
    Fernández-Rodriguez CM; Prieto J; Zozaya JM; Quiroga J; Guitián R
    Gastroenterology; 1993 Apr; 104(4):1139-45. PubMed ID: 8462804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
    La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
    Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interrelationships between systemic hemodynamics, urinary sodium excretion, and renin-angiotensin system in cirrhosis.
    Aliaga L; Zozoya JM; Omar M; Mediavilla JD; Prieto J
    Acta Gastroenterol Belg; 1995; 58(2):213-21. PubMed ID: 7571982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Portal and systemic hemodynamics and humoral factors in cirrhosis with and without ascites.
    Hayes PC; Cumming AD; Craig KJ; Watson M; Bouchier IA
    Am J Gastroenterol; 1992 Oct; 87(10):1433-8. PubMed ID: 1415100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transjugular intrahepatic portosystemic stent shunt: effects on hemodynamics and sodium homeostasis in cirrhosis and refractory ascites.
    Wong F; Sniderman K; Liu P; Allidina Y; Sherman M; Blendis L
    Ann Intern Med; 1995 Jun; 122(11):816-22. PubMed ID: 7741365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sympathetic nervous activity in cirrhosis: the relationship between peripheral hemodynamics and renal function changes].
    Fernández Rodríguez CM; Prieto J; Quiroga J; Prada I; Rodríguez D; Pereira S; Pallarés A; Andrade A; Penas J
    Gastroenterol Hepatol; 1996 Apr; 19(4):194-8. PubMed ID: 8665356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in plasma endothelin-1 and Big endothelin-1 induced by transjugular intrahepatic portosystemic shunts in patients with cirrhosis and refractory ascites.
    Martinet JP; Legault L; Cernacek P; Roy L; Dufresne MP; Spahr L; Fenyves D; Pomier-Layrargues G
    J Hepatol; 1996 Nov; 25(5):700-6. PubMed ID: 8938548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Taurine-induced diuresis and natriuresis in cirrhotic patients with ascites.
    Gentile S; Bologna E; Terracina D; Angelico M
    Life Sci; 1994; 54(21):1585-93. PubMed ID: 8196477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic, renal, and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis.
    La Villa G; Barletta G; Pantaleo P; Del Bene R; Vizzutti F; Vecchiarino S; Masini E; Perfetto F; Tarquini R; Gentilini P; Laffi G
    Hepatology; 2001 Jul; 34(1):19-27. PubMed ID: 11431729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of nitric oxide inhibition by methylene blue in cirrhotic patients with ascites.
    Kalambokis G; Economou M; Fotopoulos A; Bokharhii JA; Christos P; Paraskevi K; Konstantinos P; Katsaraki A; Tsianos EV
    Dig Dis Sci; 2005 Oct; 50(10):1771-7. PubMed ID: 16187171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced urinary excretion of cGMP in liver cirrhosis. Relationship to hemodynamic changes, neurohormonal activation, and urinary sodium excretion.
    Fernández-Rodriguez CM; Prieto J; Quiroga J; Zozaya JM; Andrade A; Rodriguez-Ortigosa C
    Dig Dis Sci; 1997 Jul; 42(7):1416-20. PubMed ID: 9246039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of upright posture and physical exercise on endogenous neurohormonal systems in cirrhotic patients with sodium retention and normal supine plasma renin, aldosterone, and norepinephrine levels.
    Saló J; Ginès A; Anibarro L; Jiménez W; Bataller R; Clària J; Ginès P; Rivera F; Arroyo V; Rodés J
    Hepatology; 1995 Aug; 22(2):479-87. PubMed ID: 7635416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal sympathetic and renal response to sodium restriction in compensated cirrhosis.
    Simón MA; Díez J; Prieto J
    Gastroenterology; 1991 Nov; 101(5):1354-60. PubMed ID: 1936807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscle sympathetic nerve activity and renal responsiveness to atrial natriuretic factor during the development of hepatic ascites.
    Morali GA; Floras JS; Legault L; Tobe S; Skorecki KL; Blendis LM
    Am J Med; 1991 Oct; 91(4):383-92. PubMed ID: 1835288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperinsulinemia in preascitic cirrhosis: effects on systemic and renal hemodynamics, sodium homeostasis, forearm blood flow, and sympathetic nervous activity.
    Wong F; Logan A; Blendis L
    Hepatology; 1996 Mar; 23(3):414-22. PubMed ID: 8617419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impairment of renal function during moderate physical exercise in cirrhotic patients with ascites: relationship with the activity of neurohormonal systems.
    Saló J; Guevara M; Fernández-Esparrach G; Bataller R; Ginès A; Jimenez W; Ginès P; Rivera F; Arroyo V; Rodés J
    Hepatology; 1997 Jun; 25(6):1338-42. PubMed ID: 9185749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium handling in patients with well compensated cirrhosis is dependent on the severity of liver disease and portal pressure.
    Jalan R; Hayes PC
    Gut; 2000 Apr; 46(4):527-33. PubMed ID: 10716683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.